Skip to main content

Advertisement

Log in

Intraoperative findings of abnormal muscle response for hemifacial spasm following botulinum neurotoxin treatment

  • Original Article - Functional Neurosurgery - Other
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Objective

This study aimed to investigate the effect of preoperative botulinum toxin (BTX) injection on intraoperative abnormal muscle response (AMR) in patients with hemifacial spasm (HFS).

Methods

A total of 104 patients (32 men, 72 women) who underwent microvascular decompression (MVD) for HFS were included in this study. A total of 62 patients without and 42 patients with preoperative BTX treatments were assigned to group A and group B, respectively. AMR recordings were obtained from the orbicularis oculi and mentalis muscles by stimulation of the marginal mandibular branch and zygomatic branch of the facial nerve, respectively. The intraoperative AMR monitoring findings and therapeutic effects were compared between groups A and B.

Results

The rates of the patients with unavailable AMRs recorded from the orbicularis oculi muscles in group B (38.1%) were significantly higher than those in group A (14.5%, p = 0.006). Moreover, in cases with over 4 times BTX injection, the recordings of AMR from the orbicularis oculi muscles were poorer than the cases with less BTX injection (p = 0.001). There were no significant differences in the rates of the patients with unavailable AMRs recorded from the mentalis muscles between the two groups. There were no significant differences in the surgical results obtained between the two groups.

Conclusions

Preoperative BTX injections should be less than 4 times to ensure effective AMR monitoring. MVD using AMR monitoring is useful for patients with HFS who were previously treated by BTX as well as those who were not treated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Biglan AW, May M, Bowers RA (1988) Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum). Arch Otolaryngol Head Neck Surg 114(12):1407–1412

    Article  CAS  Google Scholar 

  2. Elston JS (1992) The management of blepharospasm and hemifacial spasm. J Neurol 239(1):5–8

    Article  CAS  Google Scholar 

  3. Gardner WJ (1962) Concerning the mechanism of trigeminal neuralgia and hemifacial spasm. J Neurosurg 9:947–958

    Article  Google Scholar 

  4. Habeych ME, Shah AC, Nikonow TN et al (2011) Effect of botulinum neurotoxin treatment in the lateral spread monitoring of microvascular decompression for hemifacial spasm. Muscle Nerve 44(4):518–524

    Article  CAS  Google Scholar 

  5. Hatem J, Sindou M, Vial C (2001) Intraoperative monitoring of facial EMG responses during microvascular decompression for hemifacial spasm. Prognostic value for long-term outcome: a study in a 33-patient series. Br J Neurosurg. 15(6):496–9

    Article  CAS  Google Scholar 

  6. House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93(2):146–147

    Article  CAS  Google Scholar 

  7. Jannetta PJ (1976) Microsurgical approach to trigeminal nerve for tic douloureux. Prog Neurol Surg 7:180–200

    Article  Google Scholar 

  8. Jannetta PJ (1980) Neurovascular compression in cranial nerve and systemic disease. Ann Surg 192:518–525

    Article  CAS  Google Scholar 

  9. Jost WH, Kohl A (2001) Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm. J Neurol 248(Supple 1):21–24

    Article  CAS  Google Scholar 

  10. Kiya N, Bannur U, Yamagushi A, Yoshida K, Kato Y, Kanno T (2001) Monitoring of facial evoked EMG for hemifacial spasm: a critical analysis of its prognostic value. Acta Neurochir 143:365–368

    Article  CAS  Google Scholar 

  11. Liu MX, Zhong J, Xia L et al (2017) The significance of abnormal muscle response monitoring during microvascular decompression for hemifacial spasm. Acta Neurochir Suppl 124:297–301

    Article  Google Scholar 

  12. Møller AR (1999) Vascular compression of cranial nerves: II: pathophysiology. Neurol Res 21(5):439–443

    Article  Google Scholar 

  13. Salari M, Sharma S, Jog MS (2018) Botulinum toxin induced atrophy: an uncharted territory. Toxins (Basel) 10(8):313

    Article  Google Scholar 

  14. Wang X, Thirumala PD, Shah A et al (2013) Effect of previous botulinum neurotoxin treatment on microvascular decompression for hemifacial spasm. Neurosurg Focus 34(3):E3

    Article  Google Scholar 

  15. Yamashita S, Kawaguchi T, Fukuda M, Watanabe M, Tanaka R, Kameyama S (2005) Abnormal muscle response monitoring during microvascular decompression for hemifacial spasm. Acta Neurochir (Wien) 147(9):933–937

    Article  CAS  Google Scholar 

  16. Zhang WB, Min LZ, Zhong WX et al (2019) Surgical effect and electrophysiological study of patients with hemifacial spasm treated with botulinum toxin or acupuncture before microvascular decompression. Clin Neurol Neurosurg. 184:105417

    Article  Google Scholar 

  17. Zhu W, Sun C, Zhang Y, Xu J, Wu S (2020) AMR monitoring in microvascular decompression for hemifacial spasm: 115 cases report. J Clin Neurosci 73:187–194

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoko Nakayama.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Functional Neurosurgery—Other

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakayama, Y., Kawaguchi, T., Fukuda, M. et al. Intraoperative findings of abnormal muscle response for hemifacial spasm following botulinum neurotoxin treatment. Acta Neurochir 163, 3303–3309 (2021). https://doi.org/10.1007/s00701-021-05017-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-021-05017-5

Keywords

Navigation